Form 4 for PASG Passage BIO, Inc.
Accepted 2024-02-13 00:00:00 ET · period of report 2021-08-16 · accession 0001415889-24-003637 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-13 | 2024-02-13 | PASG | Forman Mark S | Chief MEDICAL Off | S - Sale+OE | $0.97 | -1,638 | 48.6K | -3% | -$1,589 |
| D | 2024-02-13 | 2024-02-10 | PASG | Forman Mark S | Chief MEDICAL Off | M - OptEx | — | +5,000 | 50.3K | +11% | — |
| DM | 2024-02-13 | 2021-08-16+ | PASG | Forman Mark S | Chief MEDICAL Off | A - Grant | $0.00 | +170.0K | 25.0K | New | $0 |
| D | 2024-02-13 | 2024-02-10 | PASG | Forman Mark S | Chief MEDICAL Off | M - OptEx | $0.00 | -5,000 | 10.0K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-13 | S | D | 1,638 | $0.97 | 48,631 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-10 | M | A | 5,000 | — | 50,269 | D | — | — | (F1) Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. |
| 3 | Derivative | Employee Stock Option (right to buy) | 2021-08-16 | A | A | 130,000 | $0.00 | 130,000 | D | $10.84 · — to 2031-08-15 | 130,000 Common Stock | (F3) The stock option vests as to 25% of the total shares on August 16, 2022, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
| 4 | Derivative | Restricted Stock Unit | 2024-02-10 | M | D | 5,000 | $0.00 | 10,000 | D | — · — to — | 5,000 Common Stock | (F1) Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. (F5) 1/3 of the RSUs will vest on February 10, 2024 and 2/3 of the RSUs will vest on February 10, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date. |
| 5 | Derivative | Restricted Stock Unit | 2022-02-10 | A | A | 15,000 | $0.00 | 15,000 | D | — · — to — | 15,000 Common Stock | (F1) Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. (F5) 1/3 of the RSUs will vest on February 10, 2024 and 2/3 of the RSUs will vest on February 10, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date. |
| 6 | Derivative | Employee Stock Option (right to buy) | 2022-02-10 | A | A | 25,000 | $0.00 | 25,000 | D | $4.52 · — to 2032-02-09 | 25,000 Common Stock | (F4) The stock option vests as of 1/48 of the total shares monthly beginning on March 10, 2022 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |